Search This Blog

Tuesday, January 22, 2019

Why do 40 doctors still get it wrong? Isn't the science clear?


A 50-year male, an academic, a PhD in biology came to see me, somewhat reluctantly. I was a last resort, an afterthought. He was suffering with a disabling mix of symptoms: headaches, joint pain, pins and needles, overall weakness, fatigue, fevers, night sweats and trouble thinking clearly. He still worked 5 days a week, thankfully a government job, something he knew inside and out. He still struggled to get through the day crashing on the sofa the moment he got home. The guy lives in a wooded area of Prince George’s County MD around the DC beltway. Deer camp in his back yard. He  previously prided himself in his athletic prowess, doing motor cross and competitive downhill skiing. He spent hours in the back yard, gardening and clearing brush. Chopping wood for the fireplace. Sports were a distant memory now. He had seen by 40 or so doctors, some of the best he thought. University professors and the like. No diagnosis could be made. It was suggested it was psychosomatic and he needed to see a psychiatrist.  Sure, he felt depressed and considered the diagnosis, but he knew that wasn’t it. He admits to epic tick exposure, 25 ticks on his body yearly for more than 10 years. He found a few attached ticks but thought he always remove them early. He had no history of a bull’s eye rash or other known Lyme symptom – he thought, at least that is what the books and reliable sources said.  His doctors said he most certainly did not have Lyme disease. 
To my way of thinking the likelihood of tickborne illness approached 100%.  Maybe he removed most ticks, but it is almost certain he missed some.  Larval and nymph forms are stealthy and sometimes impossible to find.  And – what else could cause that particular mix of symptoms? 
His Lyme tests were negative.  I repeated his Western Blot; it was clearly negative.  Tickborne testing was negative except the blood Giemsa slide which showed parasites inside his red blood cells. 
There is much talk about how long ticks need to be attached to transmit Lyme. Its an open question. I haven’t heard any discussion about how long it takes to transmit Babesia. Nonetheless, I thought it was unlikely that Babesia was responsible for most of his symptoms.  Lyme must be there as well and perhaps other coinfections. 
Doctors today are not taught to think and solve complex clinical problems and may worse, risk penalty if they dare do so. Docs are taught cookbook guidelines. “Medicine for Dummies.” Dogma states: Lyme patients always get rashes and are positive by the ELISA/Western Blot. Science informs that many patients do not get rashes, and many are “seronegative.” Undisputed fact. Why are doctors fed bad facts? ID doctors clearly have an agenda when it comes to Lyme disease. 
Guidelines are specialty driven.  ID doctors think about germs, cardiologist hearts, nephrologists kidneys and so on. Medicine is divided into various narrowly focused specialties. 
Primary care doctors should be the ones to put things together, integrate all the reports and data. But they are too busy or scared.  This is crazy.  
I am speaking from an allopathic perspective, fact based, and science based (my perspective).  An integrative, holistic approach must look at the interplay of genetic, environmental and psychosocial factors and the complex interplay amongst the various organ systems and “virtual” organ systems, the most important of which is the immune system. Germs are now and always have been the most important environmental factor associated with human disease. 
Infection has an established role in cardiovascular disease and cancer. Infection plays a role in autoimmune disease and perhaps much more. 
Science describes new and emerging multisystem diseases:  dysautonomia, mast cell activation syndromes and others for which there is scientific understanding.  Their existence is settled science. 
Elusive syndromes such as fibromyalgia, CFS, migraines are partially understood scientifically. There existence settled science. 
And posttreatment Lyme disease syndrome, a valid, across the board accepted diagnosis, of which a lot has been written is settled science diagnosis. 
From a mainstream medical perspective, the most likely diagnosis should be posttreatment Lyme disease syndrome. The cause of the disease (PTLDS), according to authorities is not understood. 
Why isn’t Lyme the most likely diagnosis?
Come on. 
Politics? Willful misdirection on the part of the mentors and supposed experts? IDSA?
There are likely many conflicts of interests and the fog of a paradigm war clouds the truth – not to mention hubris with reputations and careers on the line. 
The academic world, no matter the field, is fraught with politics and political correctness. In medicine lives are on the line. The culture of guru – ism is outdated and dangerous. 
The ID agenda must be exposed and squelched. 
When you open the door to PTLDS you open the door to chronic Lyme disease. (Cause unknown). The spirochetes persist in test tubes and animals – and humans. If this is true (it is), perhaps the persistence of coinfection is also true. The science suggests a reasonable theory is persistent infection plays a significant role in the perpetuation of  PTLDS.   Lyme is a multisystem, immune suppressing disease. An understanding of immune mechanisms further supports the hypothesis. Opportunistic infection makes sense. 
Empiric evidence should not be ignored.  Empiricism is a time honored source of data in medicine. 
Physicians are allowed discretion. Yes, they are. Evidence based medicine as described in UpToDate admits to biases and limitations and allows for discretionary use of its findings and recommendations.  The IDSA admits only 20% of their guidelines are based on high level evidence; their guidelines in general are largely opinion driven. The IDSA states guidelines are recommendations only and do not dictate gospel. How did these guidelines become gospel, the word of God?
There is a turf issue at play.  Specialists want to maintain control over their slice of the pie. But specialists are unable to look at the whole pie.  Only thoughtful generalists (or others with that perspective) can take in the depth and breadth of the entire pie can do so.  The pie only gets larger and more complex with each passing year. 
An allopathic, fact based, common sense based, and science-based understanding of Lyme and related infections ultimately leads to an ILADS’s -type understanding of the illness. It is inevitable. All roads lead to Rome. The logic and science are unassailable. 
It shouldn’t have taken over 40 doctors. Hundreds of tick bites? Specialty driven biases blocked the obvious answer at every step. A system of checks and balances is absent. 
The diagnosis may not be 100% clear or certain. A working diagnosis is a place to start. 
The outstanding question should relate to appropriate therapy. How do you treat chronic Lyme and coinfections, or specifically, how do you treat this patient?
The best place to look for answers is doctors like me who have been treating the disease for years and decades. 

Monday, January 14, 2019

Treating Lyme, 2019, a brief overview: The more things change the more things remain the same ( Plus ça change, plus c'est la même chose)

Things are changing slowly.

My paradigm for treating Lyme is in constant flux.  Lyme is in general, a systemic, multisystem disorder characterized by widespread inflammation. I try to understand the underlying cause of inflammation. Inflammation is due to an immune response which may be appropriate, inappropriate and/or autoimmune.  Mast cell activation (MCAS), for example, is an example of inappropriate immune response/inflammation which may be triggered by infection.  Germ persistence is a key factor. But related autoimmunity is important. For example, Lyme may trigger rheumatoid arthritis – or something that looks like it.  We know that other factors that incite systemic autoimmune responses, for example, gluten in susceptible patients may exacerbate symptoms of Lyme.. A variety of other autoimmune manifestations need be considered, for example, PANS (PANDAS) causing autoimmune encephalitis. Consider POTS, another multisystem disorder which can look like Lyme. Underlying genetic, somatic disorders may contribute to symptoms, for example, Ehlers Danlos syndrome, a connective tissue disorder. 
Following “Sutton’s Law” I try to go where the money is.  I treat symptoms, like disturbed sleep and fatigue. Increasing functionality is key to restoring quality of life. I focus on: Lyme, coinfections, inflammation, genetic disorders and symptoms. Nutritional issues are important.  I put aside: viral infection, heavy metal toxicity, mold toxins and other confounding issues that seem popular. (Antiviral meds can be very helpful). I put aside “adrenal fatigue.” Universally, chronically ill patients and Lyme patients develop adrenal dysfunction. This will usually fix itself when the underlying disease is treated, and treatment can backfire. Thyroid disease/dysfunction is another matter and must be treated. The role of epigenetics is unclear and not something I focus on early in treatment.  The notion that antibiotics alone will fix everything is incorrect. 
The antibiotics, antimicrobials mentioned are examples and not recommendations. Only a treating physician can decide what might be appropriate. Choice of antibiotics is driven by symptoms.  Lyme” coverage” is always present, if at a lower intensity.  If Lyme is the main driver of symptoms a cocktail of 3 drugs may be used.  Doxycycline, Rifampin and Tindamax is an example of a 3-drug cocktail – there are many others.  When rifampin is used Bartonella Herxheimer reactions may appear and may be severe.  If Bartonella is the primary target a cocktail of Zithromax or Biaxin, doxycycline and Rifampin may be used – and others.  If Babesia is the main issue a Cocktail of Zithromax, Mepron and doxycycline and others may be considered. Depending on the patient, one drug may be added, incrementally, every 3-4 days. The meds listed are exemplary.  Details including dosages and management of Herxheimer reactions is beyond the scope of this brief post. Transition from one therapy to another also not discussed here.  In some situations, for example, acute Lyme encephalopathy, IV Rocephin is used out of the gate. Rocephin remains the first line of intravenous therapy. I use continuous rather than pulse therapy. When a patient improves, I transition to pulse therapy and fewer antibiotics. Drugs like Dapsone may have a role impacted Babesia and Lyme. There are many other antibiotics and antibiotic combinations not mentioned here. 

Every patient is different and requires a unique treatment plan.  There are no "protocols."
Co-morbidities (other diseases, syndromes) are addressed.  Antibiotics don’t fix everything. 
Insomnia is treated with a variety of agents, e.g.: doxepin, Restoril, Seroquel, etc – whatever it takes. I routinely order sleep studies.  Sleep disorders including sleep apnea are common accompaniments of Lyme. I am frequently surprised to meet patients with 10 years or more of chronic fatigue who have never had a sleep study. 
Fatigue can frequently be effectively treated with drugs such as Nuvigil and others. 
Depression and pain must be treated.  I put the two together because some of the therapies dovetail.  Patients may tolerate various antidepressants in a way I cannot predict.  Some patients are on SSRI, e.g. Lexapro. The patient may not tolerate Cymbalta which is effective for pain. A very low dose of amitriptyline, e.g. 10 mg 1-3 daily can confer to the SSRI the pain modulating properties of Cymbalta without amitriptyline side effects. Gabapentin is indispensable. Muscle relaxers like Zanaflex or Flexeril, when dosed properly can be very effective.  Ketamine, effective for pain and depression is the drug of the future, already in use. There are numerous other approaches. 
Brain fog, cognitive impairment can be treated in part with supplements and prescription drugs like Namenda. 
Inflammation can be treated with supplements like curcumin e.g Theracurmin and Wobenzym, etc.  Rarely short courses of steroids and/or other immune modulators like Plaquenil and biologics may be considered. 
Adjunctive therapies may be very helpful, e.g. hyperbaric oxygen therapy, saunas, and perhaps EMF therapy. 
Ultimately, graded exercise is important. 
Treatment must be paced.  Herxheimer reactions must be heeded.   
We must exclude: immune deficiency disorders, e.g. low IgG and subclasses (IVIG may be very helpful); mast cell disorders; nutritional disorders; autoimmune disorders, e.g. thyroid disease and pernicious anemia and many other medical disorders.  A problem list is created for each symptom.  A differential diagnosis list is attached to each symptom to be revisited if needed.
When a therapy doesn’t work as expected the treatment and/or diagnosis must be reconsidered. 
To summarize:  Aggressive, frequently 3 agent therapy required. Treat other syndromes which may be present. Treat symptoms. Increase function and quality of life.  Address the most likely causes of illness. 

I do things differently from some of my colleagues.  I incorporate many mainstream medical therapies, practices (baby and bathwater).  This treatment approach has been very effective.

The approach is science based, allopathic but translational, incorporating new ideas, theories and clinical therapies. I try to keep things focused and simple (it is obviously quite complicated). 
The above represents opinions of the author, presented for educational purposes only and not intended for any clinical purposes, including the diagnosis or treatment of any patient.

Monday, December 17, 2018

Dapsone, wonder drug? Not just about killing germs


People have been excited about trying Dapsone for PTLDS.  Horowitz has had good clinical results. Then Zhang did the test tube trials and it was a bust. It’s a sulfa drug and I have not been impressed using sulfa drugs treating Lyme.  Dapsone is used for leprosy, skin conditions including acne and dermatitis herpetiformis – the skin condition associated with celiac disease. With this portfolio I wouldn't have thought Lyme.  Dapsone may be a true wonder drug, one off the radar since it has been around forever (since 1937, predating penicillin, first synthetized in 1908) and there is no money in it for pharmaceutical companies. But what a drug! 

There are many ways the drugs may be repurposed and it is not just about killing germs, at least not directly.
Dapsone has tremendous anti-inflammatory properties with widespread effects on immune function. It positively impacts:  effector cells, cytokines, adhesion molecules, prostaglandins, leukotrienes, interleukins, tumor necrosis factor, leukocyte activation, ROS (reactive oxygen species), folate antagonist (this I knew) and a lot more. 
It is active against bacteria and protozoa, including malaria (Babesia?). 
It is bacteriostatic, not bactericidal and suppresses: strep, staph, pneumococcus, mycobacteria and more. 

I has been successfully used in rheumatoid arthritis with efficacy comparable to more toxic drugs.
It has steroid sparing effects which may make it useful in a wide variety of inflammatory and autoimmune disorders
It prevents UV associated photosensitivity (think doxy during the summer). 
It is well adsorbed into all tissues, including the brain. It may have neuroprotective effects (human stroke study). ?Brain fog in Lyme patients. 
It may have anti-cancer effects, even against brain tumors. 
It might be effective for life extension (works in a worm).  We are not worms.  
It may help kill Lyme through non-antibiotic effects. For example, it improves immune function and generates ROS which have natural antibiotic properties. 
There is much more.
It has potential toxicity and side effects which must be monitored.  

It sounds too good to be true, so I include the reference.

Archives of Dermatology (2014) 306:103-124, Wozel, Blasum (University of Dresden, Germany)
Open access with extensive references.

Saturday, December 15, 2018

Biofilm induced inflammation in mouse model and rapid relapsers


Thank you, Dr. Zhang, for your dedication and hard work.  The latest paper published October 11, 2018 is groundbreaking. 
The latest research has moved from the test tube to the mouse model.  Test tube research cannot be applied directly to human medical care and neither animal model research, but it moves the ball closer to the goal.
Doctor Zhang has both an MD and a PhD. He is highly skilled researcher but also has the bona fides to discus clinical, human disease with credibility. 
He speaks of PTLDS, using the term frequently with words carefully chosen. He states the cause of PTLDS is unknown.  But the hypothesis that persistent infection plays a large role is written between the lines. 
I must thank him first for describing 2 types of PTLDS.  This is something I have long railed about.  In the first type(type 1 PTLDS) a patient receives early treatment and experiences clinical failure. In the second (type 2 PTLDS), the diagnosis is delayed and therefore early treatment is never provided. 
 The 4 NIH sponsored clinical trials examined only type 1 PTLDS.  The most recent trial was performed more than 12 years ago. The trials were limited with small patient numbers and have been controversial since day one.  The meaning and interpretation of the study results has been hotly contested.  Dr. Fallon’s expressed beliefs which contradict those of the IDSA were recently described on these pages. 
The IDSA has recently stated that more funding for Lyme research is unnecessary since all is already known. This is frightening. When is more data, evidence, information and science a bad thing?  I thought suppression of scientific inquiry is something left behind with the middle ages. 
For me one of the clinical mysteries has been the rapidity with which clinical symptoms may relapse when antibiotics are stopped. I think the latest study findings provide clarity here. 
 Lyme bacteria are pleomorphic and exhibit a great degree of phenotypic variability.  In layman’s words “they act like shape shifting aliens” which have widely invaded host bodies. 
The Lyme bacterium is a long, thin, twisted bacteria, a spirochete of the genus Borrelia. There are various species and strains which may cause human disease. 
 Dr. Zhang describes 3-4 variations. The spirochetes may be aggregated in a rapidly growing biomass mathematically referred to as a logarithmic growth phase.  One might think this group with its very high numbers causes the most harm and one would be wrong.  a second group he calls microcolonies (aggregated biofilm like colonies). This is a stationary group showing no active growth.  Individual spirochetes, free swimming are planktonic variants.  In microbiology, planktonic bacteria are distinguished from organisms confined to biofilms.  Most of the planktonic bacteria are round forms. This is not something I have seen described with any other pathogenic bacteria. 
Mice joints are infected (inoculated) with one of the 3 forms.  The biofilm forms caused the greatest joint inflammation in the shortest time.  Planktonic forms came in second place and the least joint inflammation was seen with the large number of actively growing spirochetes.  

The Lyme bacteria which are easily killed do not appear to be the problem. The few do more harm than the many. 
Doctor Zhang suggests that the host may be inoculated with biofilm colonies at the time of the tick bite. I suspect it doesn’t matter that much. There is fluidity.  Round forms and biofilm forms arise quickly irrespective of the inoculum. 
Persister forms express more virulence factors such as decorin binding protein, noted in the paper. 
That brings us back to the question: why do patients relapse quick when antibiotics are withdrawn?

This is what I envision.  The bacteria that cause relapse are dug in and battle hardened and barely kept in check with long term antibiotics. 
Any Star Trek fans? The Starship Enterprise (us) is shooting missiles(antibiotics) at the enemy Klingon ship (Lyme persisters). A force shield is in place and the projectiles can’t penetrate enemy strongholds.   When the Enterprise runs out of ammo the enemy drops it shields and the Klingons open fire. Ouch.

Wednesday, November 14, 2018

PTLDS vs chronic Lyme disease

There has been a lot of buzz about Posttreatment Lyme disease syndrome, PTLDS.

A number of papers over the past couple of years have described the syndrome, working towards a common understanding. Mostly the papers have been written by experts on the "I believe in chronic Lyme disease" side of the divide.

It is a narrowly defined entity. 
PTLDS applies specifically to a group of patients with a history of well characterized acute Lyme disease who were treated according to standard guidelines but despite treatment went on to develop chronic symptoms.  
Not included are:  patients who never had acute Lyme but developed chronic symptoms over time,  patients who in retrospect had acute Lyme, e.g. “summer flu” but diagnosis was delayed for months or years,  patients with a wide array of atypical, mysterious symptoms and syndromes (arguably the largest group), patients suffering with other tickborne coinfections,  patients misdiagnosed because CDC surveillance criteria were inappropriately used for purposes of clinical diagnosis,  patients misdiagnosed with a variety of illnesses ranging from fibromyalgia to MS, and patients infected with novel species of borreliosis and others. 

I have referred to the group as CLD, chronic Lyme disease. 

Nonetheless, the PTLDS name is important because it is now part of the EBM fabric. 

Patients who meet the criteria may escape the labels of psychosomatic disorder, fibromyalgia and CFS. (And, between you and me, once a concept becomes part of the EBM repertoire its definition tends to loosen quite a bit). Don't tell anyone. 

PTLDS opens a door. 
There have been only 4 NIH sponsored studies examining retreatment of Lyme patients. The meaning of the studies has been hotly debated for nearly 2 decades. The most important study is  last, published 10 years ago (Fallon 2008). In the double blinded randomized controlled study of a narrowly defined set of patients the results were positive.  The treatment group had substantial, measurable improvements. The "long-term" active therapy was 10 weeks of IV Rocephin. Cognitive improvements and constitutional improvements were present at 12 weeks. No further treatment was prescribed. At 24 weeks cognitive improvement was lost -- not durable with the 10 week treatment, but constitutional improvements persisted. 

The study conclusions have been misinterpreted and abused by those on the other side. 
Fallon writes in 2012: 
“Each of the U.S. treatment trials on PTLDS have concluded with the recommendation the course of therapy tested in each specific trial was not recommend…”
“There is a difference however between whether a trial is effective and whether or not a treatment is recommended.”
“…treatment was shown to be effective.”

To state the obvious:  antibiotics don't make you smarter or fix brain dysfunction.

The studies shows a proof of concept. 
Science provides the cover for biological plausibility:  no effort to eradicate Lyme bacteria in mice, dogs or primates has proved effective. Persistence is demonstrated in test tube studies. Even a human study demonstrated persistence. 

The logic SHOULD be clear.  It is not controversial that people touched by Lyme can be miserable and disabled.  It is not controversial that Lyme bacteria persist. It is not controversial that additional courses of antibiotics have led to clinical improvements in patients -- the best CRTs.

The clinical trials have not helped us find an optimal therapy. But that was not really their purpose. Their purpose was to determine if chronic Lyme is real (not known at the time of the studies) and if patients  improve with additional courses of antibiotics. This was the big question of the day. 

Further research will likely be guided by empiric evidence garnered by practicing physicians. 

The optimal therapy for Lyme is a very complex clinical question and it will take many years or decades for us to get there.

PTLDS patients have a real illness. The patients are suffering with a chronic disabling illness robbing them of any vestige of a quality of life.  Antibiotics have the potential to make their lives better,

PTLDS or chronic Lyme disease?  Not exactly equivalent but heading in that direction. Post Lyme syndrome: RIP.

Any serious discussion about Lyme controversies between the two camps should start here. Chronic Lyme disease --  persistent infection is proved by science.

I will be working on a talk on: How to treat Lyme. I hope some will attend.








Tuesday, November 13, 2018

Medical EMF therapy: Should you use it?


Patients are increasingly using pulsed electromagnetic frequency devices.  They have been doing so for a long time.  The question for me is: what is it all about?


EMF, electromagnetic frequencies are a form of energy which made come from a variety of sources.  It is made up of waves (which are also particles photons-- quantum mechanics – skip this part).
Think of waves on the ocean. If the waves are close together the frequency is higher. When the waves are more spaced out the frequency is lower.  Taller waves have more energy than shorter ones.

EMF is similar.

The waves are usually invisible to our eyes, the exception is light.  Color is determined by frequency of the related EMF wave.
The properties of these waves of energy are amazingly different.  Very high frequency waves are harmful to our tissues and DNA – we call this radiation.  Other frequencies are responsible for infrared saunas, microwaves, radio and TV, medical devices and much more.

Sound is also transmitted by waves but is not considered EMF energy directly.

Devices using EMF and sound (ultrasound) are promoted for medical reasons.  The intensity of the waves – the amount of energy makes a huge difference.
There is a lot of good published evidence regarding potential uses of very low frequency electromagnetic energy and very low wave (ultra-low wave) sound energy in the treatment of various ailments.  I can find no peer reviewed data for rife.

Magnets produce EMF and are in clinical use, especially for depression (transcranial magnetic therapy).  Of note, scientist still don’t know how magnets work.
Doctors swear an oath “first do no harm.”

People can get sick from EMF waves, including childhood leukemia. This energy is usually intense and constant, e.g. electrical transformer next to house.  Some people feel they are so sensitive to EMF energy that they “get off the grid” and live in homes without electricity.  
EMF medical devices appear to be safe – so far.

I am conservative, so I like treatments I consider safe like ultrasound therapy (which also speeds up bone healing) and hyperbaric oxygen therapy.

People with Lyme and its various manifestations can be desperate looking for a magic bullet. We have not found it. Patient usually require a multi-modal approach.  
I am not a naysayer.  I am not saying EMF therapy is quackery. It may work well for you. 

I am a fan TMS therapy for depression: it really works. 

I do worry about slick purveyors overselling benefits of devices. If it sounds to good to be true it is likely untrue. 

If well informed patients want to use or try EMF devices go for it.  

Friday, October 12, 2018

Babesiosis, in color

Symptoms of human babesiosis are frequently crippling and disabling and rival those caused by Lyme borreliosis. Antibody testing is available for 2 species, B. microti and B. duncani. 
The most common species might be: Babesia species (unknown). 

Common symptoms of babesiosis include:  Night sweats, persistent low grade fevers, air hunger and becoming more emotional.  

Treatment can be challenging.  I think we are getting better at eradicating it with changing, complex approaches. 

Blood Giemsa staining frequently allows us a close up look.  We are able to provide the test in our CLIA blood parasitology lab.  All of these slides (images by me) from patient blood samples show pleomorphic variations of the red blood cell parasite/protozoan.